Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-31

Clinical Trial Update: Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating a vaccine therapy for chronic phase chronic myeloid leukemia was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaccine therapy

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2011-08-31